- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06533241
Trends of Renal Biopsy in Pediatric Patients at Tanta University Hospital for 10 Years From 2012 to 2022.
August 2, 2024 updated by: Sara Mabrouk Elghoul, Tanta University
Trends of Renal Biopsy in Pediatric Patients at Tanta University Hospital
This study will be conducted on pediatric patients less than 18 years' old who underwent renal biopsy at Tanta University Hospital from 2012 to 2022.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
This study will be conducted on pediatric patients less than 18 years' old who underwent renal biopsy at Tanta University Hospital from 2012 to 2022.
The data will be collected from records:
- History taking including age and sex.
- Indications for renal biopsy.
- Methods of renal biopsy
- Complications of renal biopsy
- Adequacy of samples
- The results obtained by light microscopy
- The results obtained by electron microscopy, immunofluorescence when indicated
Study Type
Observational
Enrollment (Estimated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tanta, Qism 1
-
Tanta, Tanta, Qism 1, Egypt, 31511
- Sara Mabrouk Mohamed Elghoul
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
All pediatric patients less than 18 years' old who underwent renal biopsy.
Description
Inclusion Criteria:
- All pediatric patients less than 18 years' old who underwent renal biopsy.
Exclusion Criteria:
- no exclusions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
pediatric patients less than 18 years' old who underwent renal biopsy
pediatric patients less than 18 years' old who underwent renal biopsy at Tanta University Hospital from 2012 to 2022.
|
percutaneous renal biopsy procedure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the indications of renal biopsy
Time Frame: 3 months
|
investigate the indications of renal biopsy in pediatric patients at Tanta University Hospital for 10 years from 2012 to 2022
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
light , electron microscope and immunofluorescence results of renal biopsy
Time Frame: 3 months
|
investigate the results of renal biopsy in pediatric patients at Tanta University Hospital for 10 years from 2012 to 2022
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sara Mabrouk Mohamed Elghoul, MD, Tanta University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 28, 2023
Primary Completion (Estimated)
September 1, 2024
Study Completion (Estimated)
September 1, 2024
Study Registration Dates
First Submitted
July 30, 2024
First Submitted That Met QC Criteria
July 30, 2024
First Posted (Actual)
August 1, 2024
Study Record Updates
Last Update Posted (Actual)
August 6, 2024
Last Update Submitted That Met QC Criteria
August 2, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 36264PR419/11/23
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Renal Diseases
-
Novartis PharmaceuticalsCompletedEnd-Stage Renal Disease | Renal Failure, ChronicGermany
-
Cubist Pharmaceuticals LLCCompletedEnd-stage Renal Disease | Renal Failure Chronic Requiring HemodialysisUnited States
-
Lundquist Institute for Biomedical Innovation at...CompletedEnd-Stage Renal Disease | Chronic Renal FailureUnited States
-
Wake Forest University Health SciencesStanford UniversityCompletedRenal Transplant | Rejection Acute Renal | Rejection Chronic Renal | Rejection of Renal Transplant | Renin-Angiotensin SystemUnited States
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedChronic Renal Disease | Renal DialysisBrazil
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedKidney Transplantation | End-stage Renal Disease | Renal TransplantationUnited States
-
Genta IncorporatedCompletedNormal Renal Function | Mildly Impaired Renal Function | Moderately Impaired Renal FunctionUnited States
-
BayerCompleted
-
US Department of Veterans AffairsAbbott Diagnostics Division; Pan American LaboratoriesCompleted
-
Peripal AGUniversity Hospital Birmingham NHS Foundation Trust; Swiss Federal Institute...CompletedRenal Failure | Peritoneal Dialysis | Renal Replacement Therapy | End Stage Renal Failure on Dialysis | End Stage Renal Disease on DialysisUnited Kingdom
Clinical Trials on renal biopsy
-
UNC Lineberger Comprehensive Cancer CenterCompletedKidney Tumor | Small Renal MassUnited States
-
ProkidneyCTI Clinical Trial and Consulting ServicesCompletedType 2 Diabetes Mellitus | Chronic Kidney DiseaseUnited States
-
Assiut UniversityNot yet recruitingSystemic Lupus Erythematosus | Lupus Nephritis
-
University of California, IrvineUniversity of California, Los Angeles; University of Michigan; Vanderbilt UniversityCompleted
-
Hospital de Clinicas José de San MartínUnknownLupus NephritisArgentina
-
Hospital Authority, Hong KongCompletedKidney Transplantation | Graft RejectionChina
-
Assiut UniversityCompleted
-
The University of Hong KongNot yet recruitingLiver Transplant | Hepatorenal Syndrome, Liver Regeneration | AKI - Acute Kidney InjuryHong Kong
-
Assiut UniversityUnknown
-
University of North Carolina, Chapel HillAstellas Pharma US, Inc.Completed